The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Stepan Co

NYSE: SCL
Last

(U.S.) $61.29

Today's change-0.58 -0.94%
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.
 

Stepan Co

NYSE: SCL
Last

(U.S.) $61.29

Today's change-0.58 -0.94%
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.

Stepan Co down (U.S.)$0.58

Stepan Co closed lower Friday, dropping (U.S.)$0.58 or 0.94% to (U.S.)$61.29. Over the last five days, shares have gained 3.32% and are currently 3.21% off of the 52-week high. Shares have outperformed the S&P 500 by 22.88% during the last year.

Key company metrics

  • Open(U.S.) $60.83
  • Previous close(U.S.) $61.87
  • High(U.S.) $61.77
  • Low(U.S.) $60.67
  • Bid / Ask-- / --
  • YTD % change+23.34%
  • Volume101,723
  • Average volume (10-day)101,760
  • Average volume (1-month)92,797
  • Average volume (3-month)90,049
  • 52-week range(U.S.) $40.49 to (U.S.) $63.32
  • Beta1.14
  • Trailing P/E18.44×
  • P/E 1 year forward15.86×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.76
  • Dividend yield1.24%
  • Trailing EPS(U.S.) $3.32
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.68%

Based on its net profit margin of 4.68%, Stepan Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.47%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue419444452460
Total other revenue--------
Total revenue419444452460
Gross profit75788076
Total cost of revenue345366373384
Total operating expense399405424425
Selling / general / administrative41263832
Research & development13131312
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)000-3
Other operating expenses, total--------
Operating income20392935
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax15332431
Income after tax13251721
Income tax, total2879
Net income13251721
Total adjustments to net income--------
Net income before extra. items13251721
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items13251721
Inc. avail. to common incl. extra. items13251721
Diluted net income13251721
Dilution adjustment--0----
Diluted weighted average shares23232323
Diluted EPS excluding extraordinary itemsvalue per share0.561.090.740.93
Dividends per sharevalue per share0.190.180.180.18
Diluted normalized EPSvalue per share0.561.090.740.84